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1.1 Breast Cancer, Obesity and Quality of Life 
 
 
According to “Associazione italiana registri tumori” data, in 2015 in 
Italy 692.955 women had a diagnosis of breast cancer. Compared to 
2010, this number has grown by 19% (1). Breast cancer survivals 
report that cancer has had a great impact on their quality of life 
(QoL) due to the treatments they had undergone. QoL of these 
patients has become increasingly important because of their high 
survival rate and prolonged life expectancy (2).  
 
Lifestyle behaviours are well-established risk factors for both the 
development of breast cancer and the poorer long-term prognosis 
(3). Furthermore, obesity is an additional clinical challenge that 
influences mortality for breast cancer survivors. Several studies 
have shown that this disease is associated with a 30% high risk of 
mortality in all types of breast cancer (4, 5). As shown by Swisher et 
al, survivors of triple-negative breast cancer with BMI >25 which 
participated in a specially created program (Get Fit for the Fight®, 
controlled clinical trial NCT01498536) that comprised moderate-
intensity aerobic exercise (150 min per week, for 12 weeks) and diet 
counselling reported better results in weight loss and QoL 
compared to control group. 
 
Moreover, obesity negatively affects relationships and self-
confidence of women who survived breast cancer, and it is a risk 
factor for lower self-esteem and greater sexual dissatisfaction. These 
weight concerns affect greatly the QoL of patients.  
 
Regular exercise and healthy eating are routinely recommended for 
breast cancer survivors, and different studies have shown how they 
provide benefits both in the QoL of the patients and in decreasing 
inflammation. BMI has been associated with favourable changes in 
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leptin and adiponectin which may reflect a change in adiposity with 
intervention (6, 7). Weight loss can show promising results on 
reproductive, metabolic and psychological level. Several studies 
have demonstrated how exercise and healthy eating should be 
encouraged as a part of a cancer survivorship program, as described 
by Swisher et al (4): the Get Fit for the Fight® program consisted of 
supervised, moderate-intensity aerobic exercise three times per 
week at the exercise facility and two unsupervised sessions per 
week at home. Participants utilized a variety of exercise equipment 
(stationary bicycle, treadmill, elliptical trainer, etc.) for a total of 30 
min of aerobic exercise. The goal of the program was to complete 
150 min per week of moderate-intensity aerobic exercise, 
corresponding to 60–75 % of peak heart rate achieved on the 
exercise test. Dietary counselling consisted of two individual 
sessions with a specialist in nutrition for cancer patients. 
Participants completed a 3-day diet record during baseline testing 
before meeting individually with the dietitian. She then reviewed 
the diet record and helped participants set goals for changes, such as 
decreasing portion sizes, substituting lower-calorie options, and 
increasing fruit and vegetable intake. The goal of diet counselling 
was to decrease dietary fat caloric intake by 200 kcal per week.  
 
1.2 Breast Reconstruction 
 
 
The diagnosis of breast cancer is hard to bear for women, because 
the consequences of the mastectomy surgery affect their femininity 
and influence how much they feel comfortable in their daily life. 
Breast is a sexual organ which characterizes the body of women 
from the puberty. Feminine clothes and underwear are shaped 
taking into account a thorax with breast. Moreover, currently the 
female body is even more expected to fulfil certain aspects 
determined from the images on social media and the internet, often 
unrealistic, and this could be very stressful for a woman with such a 
diagnosis. As a consequence, patients could have difficulties to find 
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a new role in a society which has become dystopic regarding 
women’s bodies, beside facing demanding therapies and surgeries. 
 
Fortunately, in the last decades QoL for breast cancer survivors has 
improved due to the development of different techniques offered for 
both breast cancer management and breast reconstruction. 
As Nahabedian states in his work “Oncoplastic Surgery of the 
Breast”, prior of the era of William Halsted the diagnosis of breast 
cancer was often associated with few options for breast cancer 
management and poor patient survival. With Halsted radical 
mastectomy, morbidity and mortality of breast cancer diminished, 
despite the consequent deformity of the chest (8). Later, association 
between radiotherapy and simple mastectomy, performed 
preserving the pectoral major muscle, increased the availability of 
less aggressive surgical techniques (8). Nowadays, we know that 
skin and nipple areola complex can be spared without risk of local 
recurrence or decrease of the survival pattern, along with selected 
axillary dissection due to the routinely performed sentinel node 
biopsy technique. 
Although there has been a significant improvement in techniques 
developed to perform even less invasive mastectomies, all of them 
resulted in disfigurement of the breast (Table 1-1). Therefore, in 
order to reduce the deformity of the chest, breast reconstruction has 
begun to become popular and widely studied (8). 
 
Table 1-1: Development of mastectomy techniques during the years [8] 
Chronological history of operations related to total mastectomy 
   
Author Year Treatment 
Halsted 1890 Radical mastectomy 
Patey 1948 Modified radical 
mastectomy 
McWhirter 1948 Simple mastectomy 
and radiotherapy 




Noguchi 1996 Sentinel lymph node 
biopsy 
VerHeyden 1998 Subcutaneous 
mastectomy 
(malignant disease) 
Chronological history of operations related to partial 
mastectomy 
Crile 1973 Partial mastectomy 
Montague 1978 Breast conservation 
therapy 
Veronesi 1994 Segmental 
parenchymal 
excision 
Gabka 1997 Oncoplastic surgery 
Clough 1998 Reduction 
mastopexy 
lumpectomy 
Amanti 2002 Periareolar 
parenchymal 
excision 
Anderson 2005 Parallelogram 
excision patterns 
 
The techniques used for breast reconstruction consider a 
replacement both in volume and in shape, and are generally divided 
in heterologous and autologous techniques, which allow to find the 
best solution for every woman and breast (Table 1-2). 
Heterologous breast reconstruction procedures with breast implant 
or expander have widened their indication due to the development 
of acellular dermal matrices, that have permitted to extend the 
reconstruction with prosthesis also to women who have ptotic 
breast or thin skin, decreasing post-surgical pain and the damage to 
the muscles. 
Autologous breast reconstruction techniques have extended from 
classic Latissimus Dorsi flap (first described by Igino Tansini in 
1906) and TRAM or DIEP flaps (respectively, Transverse Rectus 
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Abdominis Muscle flap and Deep Inferior Epigastric Perforator flap) 
to intercostal artery perforator flaps, gluteal flaps, gracilis flap and 
lipostructure (as known as lipofilling or fat graft). 
 
Table 1-2: Development of breast reconstruction techniques during the years [8] 
Chronological history of operations related to breast 
reconstruction 
Author Year Technique  
Berson 1944 Derma-fat grafts 
Longacre 1953 Local flaps 
Snyderman 1969 Prosthetic devices 
Arnold 1976 Omentum and 
prosthetic 
Schneider  1977 Latissimus dorsi 
Hartrampf  1982 TRAM flap 
Argenta  1984 Tissue expansion 
Grotting  1989 Free TRAM flap 
Allen  1994 Perforator flaps 
 
Among these, fat grafting (lipofilling) is a widely used practice 
refined by plastic surgeons (9). Studying the history of fat graft, it is 
recognised that Czerny in 1895 performed one of the first attempts 
of breast reconstruction with fat graft, transplanting a lipoma 
excised from the dorsum to a defect originated from a wide 
mammary gland removal. Later in 1931, Lexer tried a breast 
reconstruction with axillar adipose tissue. May, in 1941, described a 
similar attempt including the fascia in the fat graft to increase the 
vascularization. Then, several other authors have attempted 
analogous procedures for breast augmentation (10). 
Illouz succeeded in a turning point in fat graft transfer technique, as 
he understood that fat could be suctioned by means of a cannula 
instead of being just surgical excised. Then, in 1991, Coleman 
described his technique called Lipostructuret® at the Congress of 
Lipoplasty Society of North America in Seattle, a real milestone in 
fat harvesting and transfer. He comprehended that fat should be 
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manipulated without causing trauma to the cells and described a 
protocol for fat manipulation (10).  
 
 
1.3 The Lipofilling Technique 
 
 
As described before, from Bircoll in 1987 to Coleman in 1995 many 
authors have contributed to the development of the technique of fat 
grafting (11). The procedure consists of three steps: 
- harvesting the fat by means of liposuction 
- processing the fat 
- re-injection of the purified fat or lipofilling (Figure 1-1). 
 
Figure 1-1: Breast lipofilling 
 
 
The success of this technique is due to the properties of the adipose 
tissue, which is an easily accessible source that can be collected by 
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procedures relatively simple, safe and repeatable with minimal 
morbidity. Adipose tissue is available in the majority of patients and 
this allows autologous grafts without immunogenic drawbacks. 
Traditionally, liposuction sites are those that have always been 
subjected to liposuction for cosmetic reasons, such as abdomen, 
flanks, hips (12). 
Fat can be transplanted in a wide range on anatomical areas with 
very different purposes; for instance, Vaienti described how 
lipofilling represents a valuable and versatile option in the 
treatment of painful neuromas of the upper limb and is also useful 
in pain syndromes of neuropathic origin treatment (12-15).  
 
Analysing just the breast related field, fat graft is employed in breast 
tissue damage related to post mastectomy radiotherapy, breast 
augmentation, postmastectomy breast reconstruction and breast 
implant complications as capsular contracture. 
In fact, in implant-based breast reconstructions, capsular contracture 
incidence has been reported ranging from 5% to 74% on behalf of 
several studies performed by implant manufacturers and 
prospective clinical studies with a considerable degree of follow-up 
(16-29). The capsular contracture is the development of a connective 
capsule around the prosthetic implant (Figure 1-2). The origin is 
unknown, but several hypotheses have been studied, such as 
inflammation, infection, hematoma, oozing of the silicone gel, the 
rupture of the prosthesis or an unspecific organism reaction to the 
implant. This capsule causes a variety of symptoms such as pain, 
induration, palpability and/or dislocation of the prosthesis itself. 
The capsular contracture can be measured in different grades (Baker 
classification) and may need surgical correction. Baker classification 
identifies three grades: grade I, described as soft capsule, normal 
breast appearance, no evidence of implant; grade II, with minimal 
capsule, palpable implant but not visible; grade III that causes 
moderate, firm breast, visible implant; grade IV characterized by 
severe, breast hard, breast distortion and discomfort or tenderness 
(30). Lipofilling is one of the most employed corrective techniques 




Figure 1-2: Capsular contracture 
 
 
Moreover, lipofilling has become successful because it could be 
performed under anaesthesia with sedation or just local anaesthesia 
as described by Coleman. 
Lipofilling procedures help to remodel breast soft tissues, increasing 
skin thickness and tropism during the period of breast expansion 
(31-36). Furthermore, several lipostructures can be performed until a 
new breast is obtained, made only by the transferred fat. In 
addition, fat graft helps to reduce the number of future revisional 
surgery procedures, often needed after the first implant breast 
reconstruction for the development of capsular contracture.  
 
Analysing the drawbacks of lipofilling, one of the most studied is 
the oncological potential of the grafted fat. Over the years, Authors 
have searched for a relationship between the placement of 
regenerated tissue in a tumour resection site and the possibility of 
promoting the tumour recurrence itself. In 2010, Rigotti and Sbarbati 
compared the incidence of local and regional recurrence of breast 
cancer between two contiguous time windows in a homogeneous 
population of 137 patients who underwent fat tissue transplant after 
modified radical mastectomy. The statistical comparison of disease-
free survival curves shown no significant differences in relapse rate 
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between the two patient subgroups before and after the fat grafting 
(37). Petit in 2012 also concluded that lipofilling could be a safe 
procedure in breast cancer patients (38). 
Although the reassuring conclusions of the studies conducted 
during these years, longer follow-up and further experiences from 
oncological series that study these findings will be received with 
great interest. In our Department of Plastic and Reconstructive 
Surgery only patients who are free of local breast disease are 
considered eligible for fat grafting, and all patients which will have 
surgery on the breast are required to provide recent radiological 
study of the breast, such as ultrasound examination and 
mammograms, no older than 12 months. 
 
The main disadvantage of lipofilling is the unpredictable resorption 
rate of the graft. Fat graft survival is reported as ranging from 55% 
to 82% (39). As described by Largo et al., most of the volume loss 
occurs within the first 3 months after surgery (40). Therefore, 
aesthetic and functional results are not stable over time, leading to 
repetition of the surgery. As a consequence, methods to increase 
graft viability are needed and researched from plastic surgeons (41, 
42). Other complications are cannula-related blunt injuries of blood 
vessels, nerves, muscles or fat embolism. 
 
 
1.4 The Adipose Tissue 
 
 
Adipose tissue is indeed a proper organ. Adipocytes express and 
secrete several endocrine hormones and protein factors such as 
leptin, adiponectin, TNF alpha and IL-6. Particularly interesting is 
that adipose tissue is capable of expression of adipokines involved 
in inflammation (list includes TNFα, IL-1b, IL-6, IL-8, IL-10, TGF-β, 
NGF) and in the acute-phase response (plasminogen activator 




With liposuction, the surgeon collects both adipocytes and a 
heterogeneous cell population named stromal vascular fraction 
(SVF), a great source of mesenchymal stem cells (MSC). This 
population contains adult stem cells named adipose-derived stem 
cells (ADSCs), progenitor cells able to differentiate in multiple cell 
lineages (43, 44). In literature, several authors have demonstrated 
the trophic effect of stromal/stem cells on scars and irradiated zones, 
as well as the beneficial effects on angiogenesis and skin 
rejuvenation. These effects can probably be linked to growth factor 
secretion by adipose stromal cells (ASC) as well as their ability to 
differentiate into multiple lineages (45). 
 
Several authors have studied how the choice of the donor site affects 
the quality of the fat itself in terms of better engraftment to the 
recipient site and lower reabsorption rate during the time. In 2010, 
Sbarbati investigated the characteristics of adipose tissue samples 
from various donor sites, evaluating their structural and 
ultrastructural characteristics and the concentration of adult stem 
cells (46). The study discovered three types of white adipose tissue 
(WAT):  
- deposit WAT (dWAT), found essentially in large fatty depots in 
the abdominal area. In this tissue cells are tightly packed and the 
collagenic components are very poor. The deep portion appears 
more fibrous than the superficial one; 
- structural WAT (sWAT), usually located in some areas in the 
limbs and in the hips. In the sWAT, the stroma is widely present 
and richly vascularized, and has adequate staminality; 
- fibrous WAT (fWAT), which has noteworthy fibrous component 
and can be found in areas where a severe mechanic stress occurs.  
The study of Sbarbati assumes that the sWAT could represent a 
privileged source for regenerative procedures based on autologous 
adipose tissues due to its microcirculation features. 
 
The percentage of fat graft resorption rate and fat graft survival are 
quite unpredictable. These variables depend on three factors: 
mature adipocyte survival, differentiation of adipose-derived stem 
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cells (preadipocytes) in mature adipocytes and the presence of 
extracellular matrix, necessary for the two previously mentioned 
factors (9). The percentage of survival of a single fat graft varies 
between 55% and 82% and this number depicts the ratio between 
the amount of fat which has been integrated in the recipient breast 
tissue and the total amount of fat grafted during the surgery (40, 47). 
As previously described by Levine et al. (39), there is no standard 
test or imaging modality to determine fat viability during the time 
after lipofilling. Usually, ultrasound is employed as ordinarily 
procedure, because it is a simple technique, easy to perform and 
with no side effects for patients.  
To increase fat graft viability, the overall homeostasis of the body 
should be improved. In literature, patient weight has been 
associated with breast reconstruction complications (48). Besides, 
weight loss has shown a decrease in inflammation (4, 6, 7). 
 
 
1.5 The Diet as a Therapy 
 
 
Several studies have observed the connection between fat resorption 
rate and presence of an inflammatory status (49-51). In 2017, Zhan et 
al investigated the influence of indomethacin, an anti-inflammatory 
pro-adipogenic drug, to the fat graft at the time of transplantation. 
In vitro, human adipose-derived stem cells were cultured in 
conditioned growth media supplemented with various doses of 
indomethacin to investigate adipogenesis and the expression of the 
adipogenic genes. In vivo, lipoaspirate mixed with stromal vascular 
fractions or indomethacin was injected into the dorsum of mice. 
Tissues were harvested at different time to evaluate histologic 
changes. It was observed that in vitro indomethacin increased up-
regulation of adipogenic genes and activation of the peroxisome 
proliferator-activated receptor-γ pathway. In vivo, the percentage 
volume of adipocytes in the indomethacin-assisted groups was 
higher than that in the lipoaspirate alone control group. However, 
indomethacin improved adipose volumes but had no effect on 
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vascularity. The authors concluded that indomethacin enhances the 
final volume retention of engrafted fat and explained this result in 
part by increased adipogenesis and possibly by the inhibition of 
inflammatory responses (49). Cervelli et al studied fat graft 
maintenance in two groups of patients which differed in body fat 
distribution and preoperative alterations of low-inflammatory 
markers, like neutrophil-lymphocyte ratio (NLR) and platelet-to-
lymphocyte ratio (PLR). They found a minor fat graft resorption 
percentage in patients with high preoperative values of PLR and 
NLR compared with the group with normal preoperative NLR and 
PLR ratios (51).  
A stimulating target is to be able to reach an anti-inflammatory 
status by the virtue of the diet. 
 
In literature, several diets have been examined for this purpose. 
There is no agreement on which is the best diet that provides real 
anti-inflammatory results on both clinical and biochemical data. 
Promising results have been demonstrated by Longo et al, who have 
reported that periodic fasting in rodents and humans can reduce 
body fat, cut insulin levels and have a various range of effects on 
metabolic markers and risk factors, including blood pressure (52). 
Nevertheless, the diet studied by Longo is not available for all the 
patients, because are not provided free of charge and offered only to 
certain physicians and not to the Italian Public Health Service. 
 
Among the other dietary regimens, once cleared of the ultimate 
cutting-the-edge trends, the Mediterranean Diet (MD) is the one that 
in different studies has shown promising results in terms of impact 
on the inflammatory status (53, 54). In 2016, the MOLI-SANI study 
addressed the relationship between the MD and platelet and 
leucocyte counts as emerging cellular biomarkers of low-grade 
inflammation, therefore the association of low- grade inflammation 
with a Mediterranean eating pattern (55). 
 
As previously described from the Seven Countries Study, an 
International Cooperative Study on coronary heart disease 
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epidemiology promoted by the American physiologist Ancel Keys 
and the Italian Flaminio Fidanza, the MD is the traditional dietary 
pattern followed by Mediterranean populations in the early 1960s 
(56-62) and is characterized by the following (Figure 1-3): 
1) abundant use of olive oil; 
2) high consumption of plant foods: fruits, vegetables, legumes, 
cereals, nuts, and seeds; 
3) moderate consumption of fish, seafood, fermented dairy 
products (yogurt and cheese), poultry, and eggs; 
4) low consumption of red and processed meat and sweets; 
5) frequent but moderate intake of wine (especially red wine) with 
meals: about 1-2 glasses per day for men and 1 glass per day for 
women (54, 63-69). 
 
The Seven Country Study investigated the benefits of the MD on 
human health, comparing European rural cohorts (the 
Mediterranean cohorts Crete, Corfù, Crevalcore, Montegiorgio and 
Dalmatia) and the non–Mediterranean cohorts (East and West 
Finland, Slavonia and Velika Krsna) (54). 
 




The PREDIMED (PREvenciòn con DIeta MEDiterrànea) study, a 
Spanish multi-center randomized trial of people at high risk for 
CVD, showed that a MD supplemented with nuts was able to 
reverse the metabolic syndrome more than a low-fat diet (54, 71). 
The metabolic syndrome is characterized by dyslipidemia and 
arterial hypertension, which are associated with increased risk of 
type II diabetes mellitus and cardiovascular diseases.  
In addition, Authors have investigated the relationship among 
adherence to the MD and quality of life in breast cancer survivors in 
the ongoing multicentre randomized controlled trial “DEDiCa 
Study” (dietary modification, physical activity and vitamin D 
supplementation) in several Italian hospitals, determining that 
higher adherence to the MD provides higher physical functioning, 
better sleep, lower pain and generally higher well-being confirming 
findings in healthy subjects (72). 
 
Overweight and obesity are linked to the occurrence of the 
metabolic syndrome as well. In fact, the adipose tissue is 
metabolically active and it is a proper endocrine organ, whose 
dysregulation causes a low-grade inflammatory state and ectopic fat 
depositions (54). The fat tissue produces inflammatory cytokines 
such as leptin, adiponectin, TNF-α, IL-1, IL-6 and pro-coagulant 
substances (PAI-1) that are associated with a chronic low–grade 
inflammation. Also, the fat tissue can produce vasoactive factors 
and molecules promoting insulin resistance (IR): free fatty acids 
(FFA), resistin and retinol binding protein 4 (54, 73). 
The apparent capacity of the traditional MD to reduce the risk of 
development and progression of cardiovascular disease, cancer and 
degenerative diseases has been attributed to nutraceutical effect of 
micronutrients and compounds with capacity antithrombotic, 
anticancer and antioxidant. Consequently, as stated by De Lorenzo, 
the healthy properties of the MD cannot be limited to any single 
nutrient, food or food component, but they have to be extended to 
the entire meal pattern and life-style (54). 
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Besides, the Mediterranean Diet is a sustainable diet in Italy, 
because all the nourishments are available on the local markets (74) 
and reflects environmental concerns and sustainability issues (70). 
The value of this diet lies in its ability to preserve the state of health 
and improve longevity, as United Nations Educational, Scientific 
and Cultural Organization (UNESCO) declared in 2010 (54). 
 
 
2. Objective of the Study 
 
 
The study aims to investigate the fat graft engraftment in patients 




2.1 Primary Endpoint 
 
 
The primary endpoint is the rate of patients with successful fat graft 
engraftment, defined as the increase of at least 1 mm in the mean 
breast soft tissue thickness after lipofilling. 
 
Co-primary endpoint is to evaluate if the adherence to the MD 
impacts on fat graft resorption rate, in terms of minor fat graft 
resorption. Patients are investigated in their dietetic habits and their 
adherence to the MD by means of a questionnaire that examines 
their usual daily and weekly consumptions. 
 
 
2.2 Secondary Endpoint 
 
 
The study collects the incidence of complications as fat necrosis, 
cysts, local recurrence, hematomas, seromas, bruising, prosthesis 
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exposure or infection, skin contour irregularities and fatty firmness 
and lumpiness, skin discoloration or swelling in both recipient and 
donor areas. Furthermore, questioning patients on their diet allows 
to have an insight on their food consumption, in particular to 
investigate their assumption of processed food.  
 
 
3. Study Design 
 
 






Patients are women who experienced breast reconstruction with 
breast expander or prosthesis after mastectomy performed due to 
breast cancer. Informed consent has been obtained from all patients. 
The study is conducted according to the Declaration of Helsinki. 
 
 
4.1 Inclusion Criteria 
 
 
- Adult females who experienced mastectomy and undergo breast 
reconstruction with lipofilling on mastectomy skin flap. 
performed on prosthesis or breast expander. 
- Skin thickness less than 1 cm in at least one breast quadrant  
- Subjects of 18-70 years of age. 
- Body mass index: 18.5-29.9 kg/m2 (normal weight to overweight, 
but not obese). 
- Ability and willingness to provide written informed consent. 
- If a patient is treated for bilateral breast reconstruction, she will 




The patient’s weight will be categorized using both body mass index 
(BMI), in kilograms per meter squared, and the World Health 
Organization Obesity Classification: 
- Underweight (BMI <18.5 kg/m2). 
- Normal weight (BMI 18.5 to 24.9 kg/m2). 
- Overweight (BMI 25 to 29.9 kg/m2). 
- Obese (BMI 30 to 40 kg/m2). 
 
 
4.2 Exclusion Criteria 
 
 
- Autologous reconstruction (DIEP flap, Latissimus Dorsi flap, etc).  
- Drug dependency. 
- Severe hypertension (systolic BP > 200 mm Hg and/or diastolic 
BP > 105 mm Hg). 
- Women who are pregnant or nursing. 
- Dietary reasons: special dietary requirements or significant food 
allergies incompatible with the study interventions, alcohol 
dependency defined as alcohol intake greater than two drinks per 
day for women. 
- Tobacco use or genetic disorders will be not considered as 
exclusion criteria. 
 
5. Investigation Plan 
 
 
- Introduction of the study to patients and consent obtaining.  
- Baseline characteristics are recorded in a database: age, smoking, 
comorbidities, unilateral versus bilateral disease and any 
chemotherapy, hormone treatment, or radiotherapy. 
- Diet questionnaire compiling. 
- Pre-operatory ultrasound (T0) to measure breast skin thickness 
and representative preoperative photographs. 
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- Lipofilling surgical time. 
- Post-operatory ultrasound after 3 months since the lipofilling 
surgery (T1), along with diet questionnaire compiling and 
representative preoperative photographs. The gain in the soft 
tissue thickness after one lipofilling is evaluated measuring the 
depth of fat tissue from skin to pectoralis muscle fascia. Data will 
be compared to the pre-operatory measure. 
- Fat graft reabsorption rate measure. 
- Patients grouping according to MD adherence (Figure 5-1), 
evaluated using the previously validated 14-item questionnaire 
for the assessment of PREvención con DIeta MEDiterránea 
(PREDIMED) (75). 
- Statistical analysis. 
- Results. 
 














6.1 The Questionnaire 
 
 
The adherence to the MD has been evaluated using the previously 
validated 14-item questionnaire for the assessment of PREvención 
con DIeta MEDiterránea (PREDIMED) (76). This survey is simple to 
understand by patients compared to other forms available in 
literature and has already been translated in Italian as previously 
applied in different studies (36, 53, 76-79).  
 
The questionnaire consists of a 14-point MD score (80) (Table 6-1), 
administered two times:  
- before the surgical procedure. The questionnaire has been 
provided to patients during the medical survey. 
- when patients have their ultrasound follow up, from three 
months after the surgical procedure. 
The double check helps to understand if there have been any 
changes in the dietary regimen. 
 
Briefly, for each item, scores 1 and 0 are assigned; PREDIMED score 
has been calculated as follows: 
- 0–5 points of the 14-item questionnaire, lowest adherence; 
- score 6–9 points of the 14-item questionnaire, average adherence; 











Table 6-1: The Questionnaire 
Table 1  
QUESTIONS 
Criteria for 1 
point 
  
1. Do you use olive oil as main culinary fat? Yes 
2. How much olive oil do you consume in a given day 
(including oil used for frying, salads, out-of-house 
meals, etc.)? 
≥4 tbsp 
3. How many vegetable servings do you consume per 
day? (1 serving: 200 g [consider side dishes as half a 
serving]) 
≥2 (≥1 portion 
raw or as a salad) 
4. How many fruit units (including natural fruit juices) 
do you consume per day? 
≥3 
5. How many servings of red meat, hamburger, or meat 
products (ham, sausage, etc.) do you consume per day? 
(1 serving: 100–150 g) 
<1 
6. How many servings of butter, margarine, or cream do 
you consume per day? (1 serving: 12 g) 
<1 
7. How many sweet or carbonated beverages do you 
drink per day? 
<1 
8. How much wine do you drink per week? ≥7 glasses 
9. How many servings of legumes do you consume per 
week? (1 serving: 150 g) 
≥3 
10. How many servings of fish or shellfish do you 
consume per week? (1 serving 100–150 g of fish or 4–5 
units or 200 g of shellfish) 
≥3 
11. How many times per week do you consume 
commercial sweets or pastries (not homemade), such as 
cakes, cookies, biscuits, or custard? 
<3 
12. How many servings of nuts (including peanuts) do 
you consume per week? (1 serving 30 g) 
≥3 
13. Do you preferentially consume chicken, turkey, or 
rabbit meat instead of veal, pork, hamburger, or 
sausage? 
Yes 
14. How many times per week do you consume 
vegetables, pasta, rice, or other dishes seasoned with 
sofrito (sauce made with tomato and onion, leek, or 






The study compares the gain in breast skin thickness in patients 
grouped according to the three categories of adherence to the 
Mediterranean diet: 
- 0–5, the lowest adherence; 
- score 6–9, average adherence; 
- score ≥ 10, the highest adherence. 
 
 
6.2 The Surgical Technique 
 
 
The procedure of autologous fat grafting requires several steps (47). 
All procedures are performed under general anesthesia. Antibiotic 
prophylaxis is routinely administered (intraoperative cefazoline 2 
g). 
Depending on the patients’ demand and fat availability, donor areas 
usually are the abdomen, hips, and inner and/or outer thighs. 
Harvesting sites are accessed through incisions placed usually in the 
creases, previous scars, stretch marks or hirsute areas (14). 
First, sites are infiltrated with combined saline solution and diluted 
adrenaline solution (1 cc of adrenaline in 1 litre of saline) (11) 
(Figure 6-1). 
  
Figure 6-1: The liposuction 




Then, the fat tissue is suctioned through the incisions made for 
infiltration of the anesthetic solution using a cannula in a sterile 
closed system created by connecting the liposuction cannula to a 
sterile drain bottle, which is connected to the liposuction machine 
on the other end. Fat grafting should be efficient and minimally 
traumatic to the grafted tissue both during the harvesting and the 
placement phases. The cannula employed is a two-holed one with a 
blunted tip, shaped like a bucket handle, to encourage harvesting of 
small parcels of fat (14). 
After aspiration, the fat is transferred in syringes which are closed 
with a plug and stored vertically in a metal grill. The syringes are 
stored on a table to allow the fatty tissue to separate from the liquid 
component (Figure 6-2). The aqueous portion can be expressed by 
pressing on the syringe (45). After a while, the syringes will show 
three different layers which differ in density. The upper level or the 
less dense level is composed primarily of oil, presumably from 
ruptured cells. The middle portion is composed primarily of 
potentially viable parcels of tissue, with more oil present in the 
upper portion and denser connected tissue present in the lower 
portion. The lowest level is the densest layer and is composed 
primarily of blood, water, and anesthetic. Discarding the oily part 
and the densest level, this procedure obtains purified fat tissue, 
preserving the integrity of the adipocytes but separating the fluid fat 
portion from the serous bloody part (Figure 6-3).  
During fat harvesting, liposuction incisions are closed using 5-0 or 6-












Figure 6-2: Processing of the liposuctioned fat 
   
 
Figure 6-3: The purified fat tissue 
 
 
Therefore, the purified body fat is placed in 3 cc syringes connected 
to cannulas and reinserted into the breast (Figure 6-4). Exposure of 
the fatty tissue to open air is avoided whenever possible, because 
histologic studies have demonstrated cytoplasm lysis of up to 50% 
of the cells exposed to air for 15 minutes (14). 
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In the end, the patient is checked for any asymmetry and 
deformities, that are meticulously corrected. 
 
Figure 6-4: Grafting of the fat 
  
 
During fat grafting, the purified fat is released in the subcutaneous 
tissue with a retrograde technique while withdrawing the cannula 
and placed along linear deposits. It is implanted in multiple tunnels 
to ensure a better contact with vascularized bed, and within each 
tunnel, it is released in small aliquot to increase the viability of 
central adipocyte cells and also to ameliorate fat particle integration 
(47). 
Fat graft is operated depending on the thickness of the 
mastectomy’s skin flap (34, 81). The amount of fat grafted is 
recorded in the patient’s notes. 
 
Risk are among the common ones described during breast 
reconstruction surgery with lipofilling. 
Risks and complications comprise: 
o Surgical anaesthesia risk and complications: both local and 
general anaesthesia involve risk. There is the possibility of 
complications, injury and even death from all forms of surgical 
anaesthesia or sedation. 
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o Surgical procedure risk and complications. There is the 







- Prosthesis exposure or infection 
- Skin contour irregularities and fatty firmness and lumpiness 
- Skin discoloration or swelling 
- Major wound separation 
- Delayed healing, scarring and poor wound healing 
- Fat and skin necrosis with tissue lost (death of transferred fat 
tissue) 
- Cysts may also form at the site of the transferred fat 
- Embolism 
- Damage to deeper structures including blood vessels, muscles 
- Nerves injury: motor and sensory nerve injury, weakness or 
loss of movements may occur. Nerve injuries may cause 
temporary or permanent loss of movement and feeling. Such 
injuries may improve over time. Painful nerve scarring is rare, 
but can occur 
- Bleeding or infections occur: additional treatment including 
antibiotics, hospitalization, or additional surgery may be 
necessary.  
o Plastic surgery risk and complications:  unsatisfactory results that 
may lead to additional surgery.  
- Bruising 
- Swelling 
- Skin contour irregularities and fatty firmness and lumpiness 
- Skin discoloration or swelling in both recipient and donor 
areas. 





6.3 Patients Follow-up 
 
 
Patients have been followed-up in the outpatient clinic to assess fat 
graft survival and potential complications as usual clinical practice. 
Follow-up visits entail: 
- A physical examination. 
- Postoperative photographs of the mammary region, according to 
standard projections. 
- Breast ultrasound. 
The follow-up protocol for this study is current standard of care for 




6.4 Ultrasound Evaluation 
 
 
Breast soft tissue thickness is calculated by means of an ultrasound 
evaluation of the depth of fat tissue from skin to pectoralis muscle 
fascia. Ultrasound evaluation is operated for every patient in every 
breast quadrant of the treated breast: upper outer quadrant, upper 
inner quadrant, lower outer quadrant, lower inner quadrant, central 
quadrant (areola-nipple) (Figure 6-5), as routine clinical practice (82-
85). The fat thickness is measured at the middle point of the 
quadrant. If the patient has no nipple, the maximal projection of 












Figure 6-5: Breast quadrants 
 
 
The ultrasound is performed pre-operatory (T0) and from three 
months after surgery (T1).  At T1, the ultrasound measures any 
variation in mastectomy skin flap thickness after lipofilling in terms 
of space from skin to pectoralis muscle fascia (Figure 6-6). Then, 
data are compared.  
 








6.5 Fat Reabsorption Rate 
 
 
As successful fat graft engraftment the study defines the increase of 










Considering that there are no published data on the proportion of 
women with low lipofilling resorption rate, we assume that this 
proportion is 50% (i.e., the proportion that maximizes the standard 
error). Consequently, a sample size of 93 patients is sufficient to 
estimate such a proportion with a precision of 10%, two-sided 
confidence interval 95%. 
 
Co-primary endpoint 
For sample size calculation the study assumes that the proportion of 
women with high lipofilling resorption rate (cases) is 50%; controls 
are the patients with low lipofilling resorption rate. Assuming that 
low adherence to Mediterranean diet is 25% in cases (high lipofilling 
resorption) and 50% in controls, a total of 98 patients (49 cases and 
49 controls) is sufficient to estimate an odds ratio of 0.33 (protective 
effect of Mediterranean diet), given the a priori probabilities 







7.2 Data Analysis 
 
 
All the patients enrolled and with complete data are included in the 
analyses. 
Since this is an observational study, descriptive summaries are 
presented for all the patients and for subgroups of patients.  
The rate of women with fat graft engraftment is calculated and 
described with corresponding confidence interval. 
Paired t-test or Wilcoxon matched-pairs signed-rank are employed 
to evaluate the mean gain in soft tissue thickness in the breasts, as 
appropriate. 
The t-test or Wilcoxon’s rank-sum test are employed to compare the 
fat gain in the two independent groups of patients (MD-adherent 
and not MD-adherent), as appropriate.  
Comparison among categorical variables is performed using chi-
squared test or Fisher exact test, as appropriate. 







The pandemic related to SARS-CoV-2 infection caused in Italy over 
71.000 deaths and one million infections from January 2020 to 
December 2020 (86). As a result, Italian Ministry of Health chose to 
stop non-oncological surgeries and controls during the peak of the 
pandemic to preserve hospital workforce, often differently 
employed in COVID-19 management, and free the operating 
theatres which have been converted to intensive care units. Udine 
Plastic and Reconstructive Surgery Department has been affected by 
the restrictions, and only post-traumatic patients and oncologic 
cases have been treated, with a drop of breast reconstructive 
surgeries and post-operatory controls. 
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This has affected the study, which collected a total of 11 patients 
with complete pre-operatory and post-operatory controls enrolled in 
the study (Table 8-1 and 8-2). 
Three patients were excluded from the study: one patient developed 
infection (the only complication observed) and had her expander to 
be removed, two patients refused to come to the post-operatory 
control due to fear of COVID-19.  
 
Table 8-1: Results I
 
 
Table 8-2: Results II
 
 
There were no patients with low adherence to the Mediterranean 
Diet in Friuli Venezia Giulia. Eight patients (73%) have an average 
adherence to the MD, three patients (27%) have a high adherence to 
the MD. All the patients expressed their same adherence to the MD 
35 
 
during the questionnaire compiling at both the pre-operatory time 
and the post-operatory time. 
Analysing the answers to the questionnaire, few patients reported to 
eat legumes, dried fruit or nuts and wine consumption. 
 
The mean age of patients is of 49 years, SD 12 y. Three patients are 
active smokers (27%), four patients have comorbidities (36%). 
The mean BMI of patients is 22, SD 1.90 (one overweight patient).  
One patient had previous lipofillings (2). 
The average amount of fat grafted is 119 cc, SD 22.85, median 115 cc, 
range [90-160 cc]. 
Four patients had pre-operatory chemotherapy (36%), 3 patients had 
pre-operatory radiotherapy (27%), 7 patients with current 
hormonotherapy (64%).  
 
The mean time of the post-operatory control is of 5 months, SD 1.89, 
median 5 months, range [3-8 months]. The mean pre-operatory soft 
tissue thickness is of 5.32 mm, SD 2.20, median 4.98 mm, range [2.76-
10.74 mm]. 
 
The mean post-operatory soft tissue thickness is of 6.20 mm, SD 
2.96, median 6.00 mm, range [3.40-14.32 mm]. The larger post-
operatory thickness was measured in the patient who had already 
undergone the lipofilling surgery. The post-operatory thickness has 
not shown normal distribution (Figure 8-1). 
 
The gain in breast soft tissue thickness from T0 to T1 is statistically 
significative: 0.062, range [0.032-3.59 mm] (p= 0.00001). 
 




Two patients have at least 1 mm of gain in soft tissue thickness. The 
study did not find statistically significative association between 
Mediterranean Diet adherence and gain ≥1 mm in thickness (p= 
0.055). 
 
Moreover, no statistically significative association among gain in 
breast soft tissue thickness and previous lipofillings, comorbidities, 
previous RT/CHT, smoke habit, hormonotherapy was found. 
No association between gain in soft tissue thickness and amount of 





























Figures 8-2 and 8-3 depict two cases of breast reconstruction with 
prosthesis (figure 8-2) and with breast expander (figure 8-3). 
 
Figure 8-2: Clinical case, breast reconstruction with prosthesis and previous radiotherapy. Lipostructure alone. 
 
 










As a result of COVID-19 pandemic, the study has collected really 
few patients to satisfy the sample size target, and this has impacted 
the possibility to find statistically significative association. 
In particular, considering the sample of 11 patients, assuming that 
the proportion of women with low lipofilling resorption rate is 50% 
(i.e., the proportion that maximises the standard error), the study 
can estimate such proportion with a precision of 30%, two-sided 
confidence interval 95%. 
Besides, the small number of patients did not allow the proper 
investigation of the role of previous RT, previous lipofillings or 
smoke habit in the reabsorption of the fat. 
 
The COVID-19 pandemic produced a wide range of time of the post-
operatory controls and ultrasounds, from 3 to 8 months, with a 
mean time of the post-operatory control of 5 months. This led to 
view the grafted fat in different times of reabsorption and did not 
allow to study patients in proper scheduled times. As described by 
Dong Won Lee et al, a strict protocol with pre-operatory measures 
and post-operatory follow-up within 1 month and after 6 months 
from the procedure, including physical examination and 
ultrasonography, allows to employ formulas to calculate the exact 
ratio of the fat reabsorption rate (82).  
The difficulties comprised also the availability of other techniques 
for fat graft retention investigation, as CT, MR or 3D photography 
(85, 87), and were extended to the difficult compliance of the 
patients. In fact, often women reported to be scared of becoming 
infected with SARS-CoV-2 if coming to the hospital for the visits. 
 
The patients had a gain in breast soft tissue thickness: the mean pre-
operatory record was 5.32 mm whereas the mean post-operatory 
one was of 6.20 mm, and the gain in breast soft tissue thickness from 
T0 to T1 is statistically significative (0.062, p= 0.00001). This result is 
in line with the literature on breast reconstruction with lipofilling 
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(39, 88). The larger post-operatory thickness was measured in the 
patient who had already undergone the lipofilling surgery, although 
the data have not been sufficiently numerous to find statistically 
significative association as previously described from other Authors 
(89). 
 
Due to the few participants, the study did not find statistically 
significative association between Mediterranean Diet adherence and 
gain ≥1 mm in thickness (p= 0.055). Furthermore, there was no 
possibility to investigate the influence of previous lipofillings, 
comorbidities, previous RT/CHT, smoke habit, hormonotherapy and 
amount of grafted fat as conducted by other Authors (45, 89). 
 
However, the study permits to observe that there is a good 
adherence to the Mediterranean Diet in Friuli Venezia Giulia. In fact, 
all the patients of the study reported to feed themselves according to 
the MD: 73% of patients described an average adherence to the MD 
and 27% of women have a high adherence to the MD. Moreover, 
several patients described changes in their dietary habits after the 
diagnosis of cancer, with active effort to do their best. This result is 
in line with the literature: a survey performed by Zhang et al among 
breast cancer survivals depicted at least 1 positive behaviour for 
improving nutrition and physical activity after cancer diagnosis or 
treatment (90).  
 
Patients reported to eat few legumes, dried fruit or nuts and 
described low wine consumption. Answering the questionnaire, 
women could have been influenced by the fact that people feel 
under exam when investigated on their diet. As a matter of fact, 
legumes are present in typical Friulan dishes, as pasta e fagioli or 
minestrone. In addition, wine consumption is quite widespread in 
Friuli Venezia Giulia. In the Author’s opinion there is no point to 
think that the answers were false, because women of the sample size 
are healthy and in a good shape, with just one patient overweight. 
Besides, other studies encourage to support a widespread habit at 






Lipofilling produces a gain in breast soft tissue thickness. 
 
Following the diagnosis of cancer, Friulan women pay attention to 
their diet and feed themselves according to the Mediterranean Diet, 
with active changes in their lifestyle. 
 
On one hand, the COVID-19 pandemic produced a lack in 
enrollment of enough patients to investigate if there is a correlation 
between fat graft resorption rate and Mediterranean Diet adherence 
in Patients who undergo the lipofilling procedure. 
 
On the other hand, the study helped to understand the dietary 
habits of the patients. 
 
Future studies could lead to guidelines for the management of 
cancer survival patients who undergo breast reconstruction with 
lipofilling, in order to suggest them a way to improve both their 
breast reconstruction results and their quality of life. 
Moreover, results will help to investigate the association among fat 
graft survival rate and the influence of single elements of the diet. 
Furthermore, other studies could characterize the ADSCs of patients 
with low lipofilling resorption rate or analyze the oxidative and 
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